Skip to content

Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients. Effetti Del Temperamento, Dell'Ansia e Della Depressione Sulla Sopravvivenza Globale e Sulla Risposta Immunitaria Del Paziente Affetto da Adenocarcinoma Colo-Rettale.

Effect of Temperament, Anxiety and Depression on Immuninity in Colorectal Cancer Patients.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01433146
Enrollment
120
Registered
2011-09-13
Start date
2011-09-30
Completion date
2012-06-30
Last updated
2012-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Colorectal Cancer, Depression, Temperament

Keywords

Temperament, Anxiety, Depression, Colorectal Cancer

Brief summary

Aim of the study is to evaluate if Temperament, Anxiety and Depression can affect Immunity and influence Survival in Colorectal Cancer Patients

Detailed description

120 prospective patients, with non-metastatic colorectal cancer, will be evaluated with questionnaires and auto-questionnaires in order to assess temperament, anxiety and depression. The immunity status will be assessed by a blood sample with the aim to evaluate cell-mediated immunity. Survivall will be related to level of anxiety/temperament/depression and cell-mediated immunity. Univariate and multivariate model analisys will be performed in order to evaluate if anxiety/temperament/depression and cell-mediated immunity can be considered as prognostic factors.

Interventions

None listed

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

diagnosis of non-metastatic colorectal cancer

Exclusion criteria

previous other primary malignancies immunodepression diagnosis of major deppression diagnosis of anxiety/depression syndrome

Design outcomes

Primary

MeasureTime frameDescription
Temperament in non-metastatic colorectal cancer patients24 monthsEvaluation if Temperament can be considered as dependent or indipendent prognostic factor for survival in non-metastatic colorectal cancer patients

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026